Metraipolis › archive › dc_e10f33acdb3e

Clinical Inertia in SGLT2 Inhibitor Use Among Elderly Patients with Type 2 Diabetes and Chronic Kidney Disease: A Comparison of Regional and University… — Europe PMC PMID:41283455

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41283455
DOI
10.3390/geriatrics10060144
License (as archived)
solo-consultazione
Archived
2026-11-08T18:14:51.096Z
SHA-256 of the archived text
2fb44809741807ce9dce33caebcfa6a59978df5f5151db7aa6a3d48a4b32b10e
Stable URL of this page
https://metraipolis.com/documento/dc_e10f33acdb3e

How to cite

Clinical Inertia in SGLT2 Inhibitor Use Among Elderly Patients with Type 2 Diabetes and Chronic Kidney Disease: A Comparison of Regional and University… — Europe PMC PMID:41283455 — Europe PMC (en), https://europepmc.org/article/MED/41283455 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e10f33acdb3e (Metraipolis archive dc_e10f33acdb3e, sha256 2fb44809741807ce9dce33caebcfa6a59978df5f5151db7aa6a3d48a4b32b10e)
BibTeX
@misc{dce10f33acdb3e,
  title = {Clinical Inertia in SGLT2 Inhibitor Use Among Elderly Patients with Type 2 Diabetes and Chronic Kidney Disease: A Comparison of Regional and University… — Europe PMC PMID:41283455},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41283455},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e10f33acdb3e; sha256 2fb44809741807ce9dce33caebcfa6a59978df5f5151db7aa6a3d48a4b32b10e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41283455. Agents can read the archived copy with the MCP tool read_document.